期刊
CHINESE CLINICAL ONCOLOGY
卷 6, 期 1, 页码 -出版社
AME PUBL CO
DOI: 10.21037/cco.2017.02.02
关键词
Breast cancer; clinical trials; systemic therapy for breast cancer; locoregional therapy for breast cancer
类别
资金
- National Cancer Institute
- Department of Health and Human Services
- Public Health Service [U10-CA-108068, UG1CA-189867, U10-CA-180822]
The National Surgical Adjuvant Breast and Bowel Project (NSABP) has made significant contributions in reducing the extent of breast surgery and in improving outcomes of patients with early-stage breast cancer through the conduct of large randomized clinical trials evaluating local and systemic therapy. In 2014, the NSABP merged with two other US National Cancer Institute-funded cooperative groups, the Radiation Therapy Oncology Group (RTOG) and the Gynecologic Oncology Group (GOG), to form NRG Oncology. The combined organization has 218 member institutions with more than 600 affiliate centers located throughout the United States, Canada, Puerto Rico, and other international sites. Over the past half century, the NSABP has entered more than 150,000 women into clinical trials of breast cancer treatment and breast cancer prevention. Many of these trials have been instrumental in establishing new standards of care for patients with breast cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据